Effects of erigeron breviscapus on renal oxidation in streptozotocin- induced diabetic rats

Chinese Pharmacological Bulletin

Volumn 20, Issue 9, 2004, Pages 1033-

  Ma, Li ^a   Zhu, Bang Hao ^a   Chen, Jian Wen ^a   Qiu, Qin Ying ^a   Zhou, Jia Guo ^a   Guan, Yong Yuan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Aminoguanidine; Diabetes mellitus; Diabetic nephropathy; Erigeron breviscapus; Maleic dialdehyde; Oxidative stress; Superxide dismutase

Indexed keywords

AMINOGUANIDINE; ANTIOXIDANT; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

CONTROL GROUP; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ERIGERON; KIDNEY; OXIDATION; OXIDATIVE STRESS; PARAMETERS; RAT; SYNTHESIS;

EID: 84871491293     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Yorek MA. The role of oxidative stress in diabetic vascular and neural disease[J]. Free Radic Res, 2003, 37(5): 471-80.
2. Tsilibary EC. Microvascular basement membranes in diabetes mellitus[J]. J Pathol, 2003, 200(4): 537-46.
3. Zhu BH, Guan YY, He H et al. Erigeron breviscapus prevents defective endothelium dependent relaxation in diabetic rat aorta [J]. Life Sci, 1999, 65(15): 1553-9.
4. Singh R, Barden A, Mori T et al. Advanced glycation end-products; A review [J]. Diabetologia, 2001, 44 (2): 129-46.
5. Hunjoo H, Kyung HK. Pathogenesis of diabetic nephropathy: The role of oxidative stress and protein kinase C[J]. Dihetes Res Clin Pra, 1999, 45(2): 147-51.
6. Lee HB, Yu MR, Yang Y et al. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy [J]. J Am Soc Nephrol, 2003, 14(8): 241-5.
7. Palm F, Cederberg J, Hansell P. Reactive oxygen species cause diabetes-induced decreasein renal oxygen tension [J]. Diabetologia, 2003, 46(8): 1153-60.
8. Hannam D, Yongsan K. Oxidative stress in diabetic nephropathy: Basic and clinical information[J]. Curr Diab Rep, 2001, 1(3); 282-7.
9. Bucala R, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in cheek pouch in response to adenosine 59-diphos-phate and bradykinin. experimental diabetes [J]. J Clin Invest, 1991, 87(2): 432-8.
10. Kedziora KZ, Luciak M, Blaszczyk J, Pawlak W. Effect of amin-oguanidine on erythrocyte lipid peroxidation and activities of antioxidant enzymes in experimental diabetes [J]. Clin Chem Lab Med, 1998, 36(10): 771-5.
11. Sung HI, Hyung JY, Sung WK, Jahei I. Effect on aminoguanidine on lipid peroxidation in streptozotocin-induced diabetic rats [J]. Metabolism, 1999, 48(9): 1141-5.